Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Ijichi

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Pancreas|January 31, 2015
Pancreatic cancer with malignant ascites: clinical features and outcomesNaminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2017
Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glandsHayato Nakagawa, Nobumi Suzuki, Yoshihiro Hirata, et al.
Cancer Science|April 21, 2012
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2014
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Kei Saito, et al.
Cancer Research|July 5, 2005
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent mannerBayasi Guleng, Keisuke Tateishi, Miki Ohta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2012
Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinomaStephen P Malkoski, Sarah M Haeger, Timothy G Cleaver, et al.
Cancer Science|December 13, 2022
HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancersHiroyuki Kato, Keisuke Tateishi, Dosuke Iwadate, et al.
Cancer Research|December 3, 2005
p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cellsMiki Ohta, Keisuke Tateishi, Fumihiko Kanai, et al.
Pancreas|December 6, 2012
Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreasKazumichi Kawakubo, Minoru Tada, Hiroyuki Isayama, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancerSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Pancreas|January 31, 2015
Pancreatic cancer with malignant ascites: clinical features and outcomesNaminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2017
Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glandsHayato Nakagawa, Nobumi Suzuki, Yoshihiro Hirata, et al.
Cancer Science|April 21, 2012
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2014
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Kei Saito, et al.
Cancer Research|July 5, 2005
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent mannerBayasi Guleng, Keisuke Tateishi, Miki Ohta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2012
Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinomaStephen P Malkoski, Sarah M Haeger, Timothy G Cleaver, et al.
Cancer Science|December 13, 2022
HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancersHiroyuki Kato, Keisuke Tateishi, Dosuke Iwadate, et al.
Cancer Research|December 3, 2005
p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cellsMiki Ohta, Keisuke Tateishi, Fumihiko Kanai, et al.
Pancreas|December 6, 2012
Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreasKazumichi Kawakubo, Minoru Tada, Hiroyuki Isayama, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancerSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 12